BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bhatt AS, Jering KS, Vaduganathan M, Claggett BL, Cunningham JW, Rosenthal N, Signorovitch J, Thune JJ, Vardeny O, Solomon SD. Clinical Outcomes in Patients With Heart Failure Hospitalized With COVID-19. JACC Heart Fail 2021;9:65-73. [PMID: 33384064 DOI: 10.1016/j.jchf.2020.11.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 42] [Article Influence: 18.0] [Reference Citation Analysis]
Number Citing Articles
1 Vidal-Perez R, Brandão M, Pazdernik M, Kresoja KP, Carpenito M, Maeda S, Casado-Arroyo R, Muscoli S, Pöss J, Fontes-Carvalho R, Vazquez-Rodriguez JM. Cardiovascular disease and COVID-19, a deadly combination: A review about direct and indirect impact of a pandemic. World J Clin Cases 2022; 10(27): 9556-9572 [DOI: 10.12998/wjcc.v10.i27.9556] [Reference Citation Analysis]
2 Palazzuoli A, Metra M, Collins SP, Adamo M, Ambrosy AP, Antohi LE, Ben Gal T, Farmakis D, Gustafsson F, Hill L, Lopatin Y, Tramonte F, Lyon A, Masip J, Miro O, Moura B, Mullens W, Radu RI, Abdelhamid M, Anker S, Chioncel O. Heart failure during the COVID‐19 pandemic: clinical, diagnostic, management, and organizational dilemmas. ESC Heart Failure. [DOI: 10.1002/ehf2.14118] [Reference Citation Analysis]
3 Davoudi F, Miyashita S, Yoo TK, Lee PT, Foster GP. An Insight Into Pathophysiology, Epidemiology, and Management of Cardiovascular Complications of SARS-CoV-2 Infection, Post-acute COVID Syndrome, and COVID Vaccine. Crit Pathw Cardiol 2022;21:123-9. [PMID: 35994720 DOI: 10.1097/HPC.0000000000000290] [Reference Citation Analysis]
4 Mohammad KO, Rodriguez JBC, Urey MA. Coronavirus disease 2019 and the cardiologist. Curr Opin Cardiol 2022;37:335-42. [PMID: 35731679 DOI: 10.1097/HCO.0000000000000958] [Reference Citation Analysis]
5 Johnson KW, Patel S, Thapi S, Jaladanki SK, Rao A, Nirenberg S, Lala A. Association of Reduced Hospitalizations and Mortality Among COVID-19 Vaccinated Patients with Heart Failure. J Card Fail 2022:S1071-9164(22)00536-X. [PMID: 35691478 DOI: 10.1016/j.cardfail.2022.05.008] [Reference Citation Analysis]
6 Greene SJ, Lautsch D, Yang L, Tan X, Brady JE. Prognostic Interplay Between COVID-19 and Heart Failure with Reduced Ejection Fraction. J Card Fail 2022:S1071-9164(22)00516-4. [PMID: 35597512 DOI: 10.1016/j.cardfail.2022.05.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Degarege A, Naveed Z, Kabayundo J, Brett-major D. Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis. Pathogens 2022;11:563. [DOI: 10.3390/pathogens11050563] [Reference Citation Analysis]
8 Llàcer Iborra P, Núñez Villota J. Clinical characteristics and risk factors for mortality on admission in patients with heart failure hospitalized due to COVID-19 in Spain. Rev Clin Esp (Barc) 2022;222:299-300. [PMID: 35512909 DOI: 10.1016/j.rceng.2022.02.002] [Reference Citation Analysis]
9 Fauvel C, Trimaille A, Weizman O, Pezel T, Mika D, Waldmann V, Cohen A, Bonnet G. Cardiovascular manifestations secondary to COVID-19: A narrative review. Respir Med Res 2022;81:100904. [PMID: 35525097 DOI: 10.1016/j.resmer.2022.100904] [Reference Citation Analysis]
10 Khodneva Y, Malla G, Clarkson S, Fu R, Safford MM, Goyal P, Oparil S, Cherrington AL, Jackson EA, Willig J. What is the association of renin-angiotensin-aldosterone system inhibitors with COVID-19 outcomes: retrospective study of racially diverse patients? BMJ Open 2022;12:e053961. [PMID: 35414547 DOI: 10.1136/bmjopen-2021-053961] [Reference Citation Analysis]
11 Mcdonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JG, Coats AJ, Crespo-leiro MG, Farmakis D, Gilard M, Heyman S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CS, Lyon AR, Mcmurray JJ, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GM, Ruschitzka F, Skibelund AK. Guía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica. Revista Española de Cardiología 2022. [DOI: 10.1016/j.recesp.2021.11.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
12 Alqahtani MS, Abbas M, Alsabaani A, Alqarni A, Almohiy HM, Alsawqaee E, Alshahrani R, Alshahrani S. The Potential Impact of COVID-19 Virus on the Heart and the Circulatory System. Infect Drug Resist 2022;15:1175-89. [PMID: 35345472 DOI: 10.2147/IDR.S351318] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
13 Fox DK, Waken RJ, Johnson DY, Hammond G, Yu J, Fanous E, Maddox TM, Joynt Maddox KE. Impact of the COVID-19 Pandemic on Patients Without COVID-19 With Acute Myocardial Infarction and Heart Failure. J Am Heart Assoc 2022;11:e022625. [PMID: 35229615 DOI: 10.1161/JAHA.121.022625] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Bruno RR, Wernly B, Wolff G, Fjølner J, Artigas A, Bollen Pinto B, Schefold JC, Kindgen-Milles D, Baldia PH, Kelm M, Beil M, Sviri S, van Heerden PV, Szczeklik W, Topeli A, Elhadi M, Joannidis M, Oeyen S, Kondili E, Marsh B, Andersen FH, Moreno R, Leaver S, Boumendil A, De Lange DW, Guidet B, Flaatten H, Jung C; COVIP study group. Association of chronic heart failure with mortality in old intensive care patients suffering from Covid-19. ESC Heart Fail 2022. [PMID: 35274490 DOI: 10.1002/ehf2.13854] [Reference Citation Analysis]
15 Louis DW, Saad M, Vijayakumar S, Ilyas S, Kokkirala A, Aronow HD. The Cardiovascular Manifestations of COVID-19. Cardiology Clinics 2022. [DOI: 10.1016/j.ccl.2022.03.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Pillai A, Lawson B. Coronavirus disease 2019 and cardiovascular diseases: collateral damage? Curr Opin Anaesthesiol 2022;35:5-11. [PMID: 34839301 DOI: 10.1097/ACO.0000000000001076] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A; Authors/Task Force Members:., ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2022;24:4-131. [PMID: 35083827 DOI: 10.1002/ejhf.2333] [Cited by in Crossref: 149] [Cited by in F6Publishing: 54] [Article Influence: 149.0] [Reference Citation Analysis]
18 John KJ, Mishra AK, Ramasamy C, George AA, Selvaraj V, Lal A. Heart failure in COVID-19 patients: Critical care experience. World J Virol 2022; 11(1): 1-19 [DOI: 10.5501/wjv.v11.i1.1] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
19 Koźlik M, Błahuszewska A, Kaźmierski M. Cardiovascular System during SARS-CoV-2 Infection. Int J Environ Res Public Health 2022;19:1184. [PMID: 35162207 DOI: 10.3390/ijerph19031184] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Crudo VL, Ahmed AI, Cowan EL, Shah DJ, Al-Mallah MH, Malahfji M. Acute and Subclinical Myocardial Injury in COVID-19. Methodist Debakey Cardiovasc J 2021;17:22-30. [PMID: 34992721 DOI: 10.14797/mdcvj.1038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 O'Donnell C, Ashland MD, Vasti EC, Lu Y, Chang AY, Wang P, Daniels LB, de Lemos JA, Morrow DA, Rodriguez F, O'Brien CG. N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker for the Severity and Outcomes With COVID-19 in a Nationwide Hospitalized Cohort. J Am Heart Assoc 2021;10:e022913. [PMID: 34889112 DOI: 10.1161/JAHA.121.022913] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Zhang Y, Wang M, Zhang X, Liu T, Libby P, Shi GP. COVID-19, the Pandemic of the Century and Its Impact on Cardiovascular Diseases. Cardiol Discov 2021;1:233-58. [PMID: 34888547 DOI: 10.1097/CD9.0000000000000038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
23 Abu Ghosh Z, Zwas DR, Keren A, Elbaz-Greener G, Israeli V, Amir O, Gotsman I. The Impact of COVID-19 Pandemic on Management and Outcome in Patients with Heart Failure. J Clin Med 2021;10:5577. [PMID: 34884277 DOI: 10.3390/jcm10235577] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Bliek-Bueno K, Mucherino S, Poblador-Plou B, González-Rubio F, Aza-Pascual-Salcedo M, Orlando V, Clerencia-Sierra M, Ioakeim-Skoufa I, Coscioni E, Carmona-Pírez J, Perrella A, Trama U, Prados-Torres A, Menditto E, Gimeno-Miguel A. Baseline Drug Treatments as Indicators of Increased Risk of COVID-19 Mortality in Spain and Italy. Int J Environ Res Public Health 2021;18:11786. [PMID: 34831541 DOI: 10.3390/ijerph182211786] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
25 Hebbard C, Lee B, Katare R, Garikipati VNS. Diabetes, Heart Failure, and COVID-19: An Update. Front Physiol 2021;12:706185. [PMID: 34721055 DOI: 10.3389/fphys.2021.706185] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Mahrokhian SH, Nordan T, Ortoleva JP, Cobey FC, Chen FY, Kapur NK, Kawabori M. Successful use of Impella 5.5 to manage cardiogenic shock complicated by COVID-19. J Card Surg 2021;36:4783-5. [PMID: 34599529 DOI: 10.1111/jocs.16038] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Girerd N, Chapet N, Roubille C, Roncalli J, Salvat M, Mouquet F, Lamblin N, Gueffet JP, Damy T, Galinier M, Tartiere JM, Janssen C, Berthelot E, Aguilhon S, Escamilla R, Roubille F. Vaccination for Respiratory Infections in Patients with Heart Failure. J Clin Med 2021;10:4311. [PMID: 34640328 DOI: 10.3390/jcm10194311] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
28 McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A; ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42:3599-726. [PMID: 34447992 DOI: 10.1093/eurheartj/ehab368] [Cited by in Crossref: 209] [Cited by in F6Publishing: 1012] [Article Influence: 209.0] [Reference Citation Analysis]
29 Essa H, Brousas S, Whybrow-Hupptaz I, Salmon T, Sankaranarayanan R. What is the effect of lockdown upon hospitalisation because of COVID-19 amongst patients from a heart failure registry? Int J Clin Pract 2021;75:e14425. [PMID: 34535050 DOI: 10.1111/ijcp.14425] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Tomidokoro D, Hiroi Y. Cardiovascular implications of the COVID-19 pandemic. J Cardiol 2021:S0914-5087(21)00243-4. [PMID: 34563439 DOI: 10.1016/j.jjcc.2021.09.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
31 Rider I, Sorensen M, Brady WJ, Gottlieb M, Benson S, Koyfman A, Long B. Disposition of acute decompensated heart failure from the emergency department: An evidence-based review. Am J Emerg Med 2021;50:459-65. [PMID: 34500232 DOI: 10.1016/j.ajem.2021.08.070] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
32 Bhatt AS, Adler ED, Albert NM, Anyanwu A, Bhadelia N, Cooper LT, Correa A, Defilippis EM, Joyce E, Sauer AJ, Solomon SD, Vardeny O, Yancy C, Lala A. Coronavirus Disease-2019 and Heart Failure: A Scientific Statement From the Heart Failure Society of America. J Card Fail 2021:S1071-9164(21)00354-7. [PMID: 34481067 DOI: 10.1016/j.cardfail.2021.08.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
33 Westermann D. Herzinsuffizienz und SARS-CoV-2. Aktuelle Kardiologie 2021;10:351-4. [DOI: 10.1055/a-1510-8661] [Reference Citation Analysis]
34 Saleh KB, Hafiz A, Alsulaiman K, Aljuhani O, Alharbi S, Alharbi A, Vishwakarma R, Albekairy A, Alkathiri A, Alanazi F, Almujarri G, Alobathani S, Alharbi Y, Zowawi HM, Badreldin HA. Clinical characteristics and outcomes of patients with heart failure admitted to the intensive care unit with coronavirus disease 2019 (COVID-19): A multicenter cohort study. Am Heart J Plus 2021;7:100033. [PMID: 34308397 DOI: 10.1016/j.ahjo.2021.100033] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
35 Mok J, Malpartida JC, O'Dell K, Davis J, Gao C, Manyam H. Vascular comorbidities worsen prognosis of patients with heart failure hospitalised with COVID-19. Open Heart 2021;8:e001668. [PMID: 34127532 DOI: 10.1136/openhrt-2021-001668] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
36 Vaduganathan M, Li D, Van Meijgaard J, Warraich HJ. Prescription Filling Patterns of Evidence-Based Medical Therapies for Heart Failure During the COVID-19 Pandemic in the United States. J Card Fail 2021:S1071-9164(21)00260-8. [PMID: 34214650 DOI: 10.1016/j.cardfail.2021.06.013] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
37 Chu JY, Kaliwal Y, Koh M, Chen R, Chow CM, Ko DT, Liu PP, Moe GW. COVID-19 and its Cardiac and Neurological Complications among Ontario Visible Minorities. Can J Neurol Sci 2021;:1-10. [PMID: 34162448 DOI: 10.1017/cjn.2021.148] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Ruge M, Gomez JMD, du Fay de Lavallaz J, Hlepas A, Rahman A, Patel P, Hoster C, Lavani P, Nair GG, Jahan N, Alan Simmons J, Rao AK, Cotts W, Williams K, Volgman AS, Marinescu K, Suboc T. Impact of pre-existing heart failure on 60-day outcomes in patients hospitalized with COVID-19. Am Heart J Plus 2021;4:100022. [PMID: 34151308 DOI: 10.1016/j.ahjo.2021.100022] [Reference Citation Analysis]
39 Roncalli J, Roubille F, Lamblin N, Girerd N, Mouquet F, Chapet N, Roubille C, Berthelot E, Galois K, Battistella P, Jondeau G, Tartiere JM, Aguilhon S, Gueffet JP, Salvat M, Damy T, Galinier M; Heart Failure Group of the French Society of Cardiology. Coronavirus disease vaccination in heart failure: No time to waste. Arch Cardiovasc Dis 2021;114:434-8. [PMID: 34099378 DOI: 10.1016/j.acvd.2021.04.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
40 Panagides V, Vincent F, Weizman O, Jonveaux M, Trimaille A, Pommier T, Cellier J, Geneste L, Marsou W, Deney A, Attou S, Delmotte T, Fauvel C, Ezzouhairi N, Perin B, Zakine C, Levasseur T, Ma I, Chavignier D, Noirclerc N, Darmon A, Mevelec M, Karsenty C, Duceau B, Sutter W, Mika D, Pezel T, Waldmann V, Ternacle J, Cohen A, Bonnet G; Critical COVID-19 France Investigators. History of heart failure in patients with coronavirus disease 2019: Insights from a French registry. Arch Cardiovasc Dis 2021;114:415-25. [PMID: 34099379 DOI: 10.1016/j.acvd.2021.04.003] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
41 Nakano H, Shiina K, Tomiyama H. Cardiovascular Outcomes in the Acute Phase of COVID-19. Int J Mol Sci 2021;22:4071. [PMID: 33920790 DOI: 10.3390/ijms22084071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
42 Greenberg A, Pemmasani G, Yandrapalli S, Frishman WH. Cardiovascular and Cerebrovascular Complications With COVID-19. Cardiol Rev 2021;29:143-9. [PMID: 33758123 DOI: 10.1097/CRD.0000000000000385] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]